Mizuho Securities USA’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Mizuho Securities USA’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,000	Closed	-$12K	–	294
2020 Q4	$12K	Buy	+25,000	New	+$53.3K	﹤0.01%	198
2020 Q2	–	Sell	-50,000	Closed	-$190K	–	162
2020 Q1	$190K	Buy	+50,000	New	+$165K	0.03%	106

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Mizuho Securities USA's BMY.RT Position: Q1 2021 in Review

Mizuho Securities USA sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 25,000 shares — an estimated $12K sold.

Mizuho Securities USA first reported a position in BMY.RT in Q1 2020 and held it in 2 quarters. The position peaked at $190K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Mizuho Securities USA reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Mizuho Securities USA sold 25,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $12K.
Mizuho Securities USA first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 2 quarters.
Mizuho Securities USA's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $190K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Mizuho Securities USA's 13F filing for Q1 2021, filed 28 Apr 2021.